Entrectinib 1108743-60-7
1 Inquiries
1108743-60-7
Pharmaceutical Grade
99%
Zison
foil bag
2023-03-31
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Entrectinib
Other Name:Benzamide,N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-;N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide;Entrectinib;RXDX 101;NMS-E 628;Rozlytrek;NMS-E628;RXDX-101;RG 6268;RG6268;RG-6268
CAS No.:1108743-60-7
Molecular Formula:C31H34F2N6O2
InChIKeys:InChIKey=HAYYBYPASCDWEQ-UHFFFAOYSA-N
Molecular Weight:560.6
Exact Mass:560.64
UNII:L5ORF0AN1I
NCI Thesaurus Code:C114984
ATC Code:L01EX14|L - Antineoplastic and immunomodulating agents
Categories:
Characteristics-
PSA:
85.5
XLogP3:5.7
Density:1.340±0.06 g/cm3(Predicted)
Boiling Point:717.5±60.0 °C(Predicted)
Flash Point:387.7±32.9 °C
Refractive Index:1.672
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Entrectinib
1 KG Dec 18, 2025 Post an enquiry for this product
